Zeenews Bureau Washington: US Food and Drug Administration (USFDA) on Monday approved Johnson & Johnson`s drug for treating multidrug-resistant tuberculosis - the first such federal approval aimed at tackling the deadly disease in 40 years. The drug named Sirturo - known chemically as bedaquilineas – is an alternative treatment for adults suffering from TB when two more powerful medications that are available, isoniazid and rifampicin, do not work, FDA said. However the regulator cautioned that the new drug should be used sparingly.
Kissing really spreads `mono` disease: Study
`People subconsciously link female names with lighter colours`